A Prospective Randomized Multi-Center Study of the Use of the LifePort Liver Transporter (LLT) System With Vasosol as Compared to Static Cold Storage in Orthotopic Liver Transplants (Perfusion to Improve Liver Outcomes in Transplantation)
Study to Evaluate Performance of LifePort Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT)
Sponsor: Organ Recovery Systems
Enrolling: Male and Female Patients
IRB Number: AAAS1509
U.S. Govt. ID: NCT03484455
Contact: Adam Griesemer, MD: 212-305-3839 / adg2101@cumc.columbia.edu
Additional Study Information: This is a prospective, randomized, multi-center, controlled study for subjects with end stage liver disease who require a liver transplant, comparing whole liver preservation via hypothermic machine perfusion (HMP) using the LLT System with Vasosol with livers preserved via static cold storage (which is standard of care). During Hypothermic Machine Perfusion, a cold solution is continuously pumped through the liver after the liver is removed from the donor. This is different from the recognized standard of care procedure of cold storage of the liver, which has no solution pumped through the liver. This study will take place at approximately 7 different sites, including here at Columbia University Irving Medical Center. A total of about 140 subjects will be enrolled. Subject care before the transplant and the majority of care after the transplant will be the same whether or not a subject chooses to participate in the study.
This study is closed
Investigator
Adam Griesemer, MD
Do You Qualify?
Are you 18 years of age or older? Yes No
Are you on the United Network for Organ Sharing (UNOS) waiting list for whole liver transplant? Yes No
Have you received a whole liver transplant in the past? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Adam Griesemer, MD
adg2101@cumc.columbia.edu
212-305-3839